These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35359936)

  • 1. Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43.
    Kim J; Kim M; Kim D; Park S; Kang M; Baek K; Choi JK; Maharjan S; Akauliya M; Lee Y; Kwon HJ
    Front Immunol; 2022; 13():835333. PubMed ID: 35359936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
    Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
    J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
    Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
    Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
    Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
    Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
    Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.
    Woldemeskel BA; Kwaa AK; Garliss CC; Laeyendecker O; Ray SC; Blankson JN
    J Clin Invest; 2020 Dec; 130(12):6631-6638. PubMed ID: 32966269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular epidemiological study of human coronavirus OC43 in Shanghai from 2009-2016].
    Yang YJ; Hu YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):55-61. PubMed ID: 29334709
    [No Abstract]   [Full Text] [Related]  

  • 12. Roles of Sialyl Glycans in HCoV-OC43, HCoV-HKU1, MERS-CoV and SARS-CoV-2 Infections.
    Sriwilaijaroen N; Suzuki Y
    Methods Mol Biol; 2022; 2556():243-271. PubMed ID: 36175638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection.
    Liang FY; Lin LC; Ying TH; Yao CW; Tang TK; Chen YW; Hou MH
    J Virol Methods; 2013 Feb; 187(2):413-20. PubMed ID: 23174159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin.
    Yang CW; Hsu HY; Lee YZ; Jan JT; Chang SY; Lin YL; Yang RB; Chao TL; Liang JJ; Lin SJ; Liao CC; Chang CS; Sytwu HK; Hung MS; Chen CT; Lee SJ
    Biochem Pharmacol; 2023 Sep; 215():115688. PubMed ID: 37481137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronaviruses and SARS-COV-2.
    Hasöksüz M; Kiliç S; Saraç F
    Turk J Med Sci; 2020 Apr; 50(SI-1):549-556. PubMed ID: 32293832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of SARS-CoV-2 N Protein-Specific Monoclonal Antibody and Its Application in an ELISA-Based Detection System and Targeting the Interaction Between the Spike C-Terminal Domain and N Protein.
    Kim D; Kim J; Park S; Kim M; Baek K; Kang M; Choi JK; Maharjan S; Akauliya M; Lee Y; Kwon HJ
    Front Microbiol; 2021; 12():726231. PubMed ID: 34950112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator.
    Chen Y; Wang X; Shi H; Zou P
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein.
    Huang CY; Hsu YL; Chiang WL; Hou MH
    Protein Sci; 2009 Nov; 18(11):2209-18. PubMed ID: 19691129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.